Medical Translation for Clinical Trials: Ensuring Patient Safety and Regulatory Compliance

Key Takeaways

• Clinical trial documents. Including Informed Consent Forms (ICFs), Clinical Study Protocols, Clinical Evaluation Reports (CERs), and Investigator Brochures. Require 100% accuracy to ensure trial participant safety and ethical approval.
• Global regulatory bodies like the UK MHRA, EU EMA, and US FDA mandate strict linguistic validation and readability standards for all patient-facing trial materials.
• Medical translation failure in clinical trials can cause ethical board delays, compromised participant safety, invalid trial endpoint data, and multi-million pound submission rejections.
• Process quality standards like ISO 17100:2015 and ISO 13485 (for medical devices) ensure strict two-tier human translation and medical expert verification workflows.
• Back-translation and cognitive debriefing are vital methodology steps required by ethics committees for patient-reported outcomes (PROs) and quality of life questionnaires.

In international clinical research, pharmaceutical companies, contract research organizations (CROs), and biotech firms rely on multi-center clinical trials across multiple countries to evaluate new treatments. With clinical trial sites distributed globally, translating trial documentation into local languages is a crucial prerequisite for regulatory approval and trial execution.

Medical translation in clinical trials is fundamentally linked to patient safety and data integrity. A subtle error in dosage instructions, inclusion/exclusion criteria, or adverse event reporting can jeopardize patient lives and invalidate years of costly research.

This guide explores the regulatory requirements for clinical trial translation, details critical document types, and outlines the rigorous quality steps required by ethics committees.

The Regulatory Framework for Clinical Trial Translation

Regulatory agencies worldwide enforce strict requirements regarding the translation of clinical documentation:

1. UK MHRA (Medicines and Healthcare products Regulatory Agency)

Post-Brexit, the MHRA regulates clinical trials in the UK. All patient-facing documentation (such as Informed Consent Forms and Patient Information Sheets) must be translated into clear, understandable English (or local languages for international sites) and submitted to the Integrated Research Application System (IRAS) for Research Ethics Committee (REC) approval.

2. EU Clinical Trials Regulation (CTR – Regulation EU No 536/2014)

Under the EU CTR, clinical trial applications across EU member states are submitted via the Clinical Trials Information System (CTIS). Each member state requires specific Part II documentation (patient recruitment materials, consent forms, suitability of facilities) in its official national language.

3. Patient Readability & Informed Consent

Ethics committees mandate that Informed Consent Forms must be written in non-technical, lay language appropriate for local patient populations. Medical linguists must accurately translate complex medical jargon into accessible phrasing without altering the clinical risk descriptions.

Critical Clinical Trial Documents We Translate

• Informed Consent Forms (ICFs) & Patient Information Sheets (PIS): Clear, patient-accessible documents outlining trial risks, benefits, and procedures.
• Clinical Study Protocols & Amendments: Detailed scientific methodologies, inclusion/exclusion criteria, and trial endpoint guidelines.
• Investigator Brochures (IBs): Comprehensive summaries of clinical and non-clinical data on the investigational drug or device.
• Patient-Reported Outcomes (PROs) & eCOA: Quality of life questionnaires, diary cards, and electronic clinical outcome assessments.
• Adverse Event (AE) & Serious Adverse Event (SAE) Reports: Urgent pharmacovigilance reports submitted to regulatory authorities within strict statutory timelines.
• Clinical Evaluation Reports (CERs): Comprehensive data summaries required for medical device CE marking and UKCA compliance.

Essential Translation Methodologies for Ethics Approval

For sensitive patient-reported outcomes and consent forms, regulatory authorities and ethics boards often require enhanced verification methodologies:

1. Back-Translation Workflow

• Forward Translation: Primary translation from source into target language by a qualified medical linguist.
• Back-Translation: An independent medical translator with no prior sight of the original source text translates the target file back into the source language.
• Reconciliation: A lead medical reviewer compares the back-translation with the original source to identify and resolve subtle nuances, ambiguities, or discrepancies.

2. Linguistic Validation & Cognitive Debriefing

For patient outcome measures (ePROs), cognitive debriefing testing is conducted with small sample patient groups in the target country to ensure that questions are understood as intended across different cultural contexts.

Medical Terminology Management & ISO Quality

Medical translation demands strict adherence to international coding standards and terminology banks:

• MedDRA (Medical Dictionary for Regulatory Activities): Standardized medical terminology used for adverse event reporting and regulatory submissions.
• SNOMED CT: Comprehensive clinical healthcare terminology for electronic health records.
• ISO 17100:2015 Certification: Mandatory two-tier workflow (specialist medical translator + independent expert revision) guaranteeing subject-matter precision.

Global LTS provides ISO 17100:2015 certified medical translation services for pharmaceutical sponsors, CROs, and clinical research institutions worldwide. Our medical translators hold formal degrees in medicine, biochemistry, or pharmacology, providing trusted support for global trial submissions.

To discuss your clinical trial translation schedule or request a confidential quote, contact our medical translation team today or visit our medical translation services page.